Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
HOUS. J. HEALTH L. & POL'Y
  • Menu
  • Articles
    • Articles
    • Comments
    • Essays
    • Health Law Perspectives
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Subscription
  • For Students
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:20455/feed
Comments
Vol. 22, Issue 1, 2022September 14, 2022 CDT

The U.S. Drug Price Impasse: Regulation, Innovation, and Public Health

Careen Ghazal, J.D.,
prescription drug pricesdrug pricingMedicareMedicare Part Daffordable caredrug pricedrug price hikes
Copyright Logoccby-4.0
HOUS. J. HEALTH L. & POL'Y
Careen Ghazal, The U.S. Drug Price Impasse: Regulation, Innovation, and Public Health, 22 HOUS. J. HEALTH L. & POL’Y 275 (2022).

View more stats

Powered by Scholastica, the modern academic journal management system